Hess Midstream Partners LP HESM 深 沪
等待开盘 10-09 09:30:00 美东时间
33.43
+0.100
+0.30%
华盛通- 最 高33.505
- 今 开33.19
- 成交量 167.46万股
- 最 低 32.79
- 昨 收 33.33
- 总市值 43.79亿
- 52周最高 43.403
- 市盈率 静 13.34
- 换手率 1.28%
- 52周最低 31.2874
- 委 比 -47.25%
- 总股本 1.31亿
- 历史最高 43.403
- 量 比 1.14
- 振 幅 2.15%
- 历史最低 -6.8673
- 每 手 1
- 风险率 2.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多比尔·格罗斯：要对当前科技股估值水平保持“谨慎”
比尔·格罗斯表示，投资者应当“对当前水平的科技股保持谨慎”，并称“当太多高科技AI公司参加同一场派对时，并非所有公司回家后都能回到温暖的床上”。 谈及当...
10-01 22:08
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
9 Analysts Have This To Say About Hess Midstream
9 analysts have shared their evaluations of Hess Midstream (NYSE:HESM) during t...
10-01 03:00
Goldman Sachs Reinstates Neutral on Hess Midstream, Announces $36 Price Target
Goldman Sachs analyst John Mackay reinstates Hess Midstream (NYSE:HESM) with a Neutral and announces $36 price target.
09-30 20:50
Wall Street's Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 8% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
09-29 19:37
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Wells Fargo Downgrades Hess Midstream to Equal-Weight, Lowers Price Target to $39
Wells Fargo analyst Praneeth Satish downgrades Hess Midstream (NYSE:HESM) from Overweight to Equal-Weight and lowers the price target from $48 to $39.
09-19 20:41
Hess Midstream trims growth plans as Chevron cuts Bakken rigs
Hess Midstream (NYSE:HESM) -1.9% post-market Thursday after providing updated guidance for the rest of FY 2025 based on updated expectations, and for 2026-27 based on an expected decrease in Bakken ri...
09-19 04:56
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
